Effect of a Gluten Free Diet on Hepatitis B Surface Antibody Concentration in Previously Immunized Pediatric Celiac Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the effect of gluten-free diet (GFD) on hepatitis B surface antibody (HBsAb) concentrations among previously immunized pediatric celiac disease (CD) subjects. Methods: We retrospectively evaluated pediatric CD subjects in serological remission who were previously immunized for hepatitis B virus as infants. The temporal relationship between HBsAb concentration, the amount of time on a GFD, and age were evaluated. Results: Overall, 373 CD subjects were analyzed: 156 with HBsAb sampled prior to GFD initiation and 217 after initiation of a GFD and in serological remission. Median age at HBsAb concentration measurement for those before and after GFD initiation was 5.3 years (interquartile range [IQR], 3.1–9.2 years) and 7.6 years (IQR, 5.4–10.9 years), respectively (p<0.001). There was no sex difference between the groups. The median time of HBsAb measurement was 2 months (IQR, 0–5.7 months) before and 12.8 months (IQR, 5.3–30.3 months) after initiation of GFD. The HBsAb concentration was low in 79 (50.6%) and 121 (55.7%) subjects before and after GFD initiation, respectively (p=0.350). Age was inversely associated with low HBsAb concentrations. Neither being on a GFD nor sex was associated with low HBsAb concentrations. Conclusion: Adherence to a GFD does not affect HBsAb concentration in children with CD. Age is inversely associated with HBsAb concentration.
Abstract
Purpose: To evaluate the effect of gluten-free diet (GFD) on hepatitis B surface antibody (HBsAb) concentrations among previously immunized pediatric celiac disease (CD) subjects. Methods: We retrospectively evaluated pediatric CD subjects in serological remission who were previously immunized for hepatitis B virus as infants. The temporal relationship between HBsAb concentration, the amount of time on a GFD, and age were evaluated. Results: Overall, 373 CD subjects were analyzed: 156 with HBsAb sampled prior to GFD initiation and 217 after initiation of a GFD and in serological remission. Median age at HBsAb concentration measurement for those before and after GFD initiation was 5.3 years (interquartile range [IQR], 3.1–9.2 years) and 7.6 years (IQR, 5.4–10.9 years), respectively (p<0.001). There was no sex difference between the groups. The median time of HBsAb measurement was 2 months (IQR, 0–5.7 months) before and 12.8 months (IQR, 5.3–30.3 months) after initiation of GFD. The HBsAb concentration was low in 79 (50.6%) and 121 (55.7%) subjects before and after GFD initiation, respectively (p=0.350). Age was inversely associated with low HBsAb concentrations. Neither being on a GFD nor sex was associated with low HBsAb concentrations. Conclusion: Adherence to a GFD does not affect HBsAb concentration in children with CD. Age is inversely associated with HBsAb concentration.
참고문헌 (16)
- Singh P, "Global prevalence of celiac disease : systematic review and meta-analysis", Clin Gastroenterol Hepatol, 16, pp.823~836 (2018)
- Sansotta N, "Celiac disease symptom resolution : effectiveness of the gluten-free diet", J Pediatr Gastroenterol Nutr, 66, pp.48~52 (2018)
- Green PH, "Clinical manifestations of celiac disease", Dig Dis, 33, pp.137~140 (2015)
- Hadler SC, "Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men", N Engl J Med, 315, pp.209~214 (1986)
- Schillie S, "Centers for Disease Control and Prevention (CDC). CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management", MMWR Recomm Rep, 62(RR-10), pp.1~19 (2013)
- Park SD, "Failure to respond to hepatitis B vaccine in children with celiac disease", J Pediatr Gastroenterol Nutr, 44, pp.431~435 (2007)
- Ertekin V, "Is there need for a new hepatitıs B vaccine schedule for children with celiac disease", Hepat Mon, 11, pp.634~637 (2011)
- Zingone F, "Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents", Vaccine, 29, pp.1005~1008 (2011)
- Husby S, "European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease", J Pediatr Gastroenterol Nutr, 54, pp.136~160 (2012)
- Katoonizadeh A, "Immune responses to hepatitis B immunization 10-18 years after primary vaccination : a population-based cohort study", J Viral Hepat, 23, pp.805~811 (2016)
- Bruce MG, "Antibody levels and protection after hepatitis B vaccine : results of a 30-year follow-up study and response to a booster dose", J Infect Dis, 214, pp.16~22 (2016)
- Hadi N, "Assessment of anti-HBs antigen in 6-to 9-year-old children routinely vaccinated via vaccination program in Iran", Med Princ Pract, 16, pp.306~309 (2007)
- Samandari T, "Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy", Pediatrics, 120, pp.e373~81 (2007)
- Heshin-Bekenstein M, "Hepatitis B virus revaccination with standard versus pre-S vaccine in previously immunized patients with celiac disease", J Pediatr Gastroenterol Nutr, 61, pp.400~403 (2015)
- Leonardi S, "Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children", World J Gastroenterol, 18, pp.5729~5733 (2012)
- Nemes E, "Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease", Pediatrics, 121, pp.e1570~6 (2008)